CVS HEALTH Corp financial data

Symbol
CVS on NYSE
Location
One Cvs Dr., Woonsocket, RI
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 80.8 % -4.49%
Quick Ratio 20 % -4.66%
Debt-to-equity 234 % -0.11%
Return On Equity 5.93 % -38%
Return On Assets 1.78 % -38%
Operating Margin 2.32 % -32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.27B shares +0.82%
Common Stock, Shares, Outstanding 1.27B shares +0.88%
Common Stock, Value, Issued 18M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.27B shares +0.8%
Weighted Average Number of Shares Outstanding, Diluted 1.27B shares +0.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 387B USD +6.44%
Costs and Expenses 378B USD +7.64%
Operating Income (Loss) 8.96B USD -27.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.5B USD -32.6%
Income Tax Expense (Benefit) 2.01B USD -17.7%
Net Income (Loss) Attributable to Parent 4.53B USD -37%
Earnings Per Share, Basic 3 USD/shares -36.2%
Earnings Per Share, Diluted 3 USD/shares -36.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.8B USD -5.76%
Accounts Receivable, after Allowance for Credit Loss, Current 40.7B USD +25.5%
Inventory, Net 17.4B USD +8.58%
Other Assets, Current 3.38B USD -35.5%
Assets, Current 75.6B USD +8.14%
Operating Lease, Right-of-Use Asset 15.5B USD -8.22%
Intangible Assets, Net (Excluding Goodwill) 26.2B USD -7.37%
Goodwill 91.2B USD -0.08%
Other Assets, Noncurrent 5.21B USD +8.67%
Assets 258B USD +2.32%
Accrued Liabilities, Current 23.1B USD +9.16%
Contract with Customer, Liability, Current 61M USD -52.3%
Liabilities, Current 94.2B USD +15.7%
Long-term Debt and Lease Obligation 57.3B USD -8.55%
Deferred Income Tax Liabilities, Net 3.6B USD -11.1%
Operating Lease, Liability, Noncurrent 14.3B USD -7.78%
Other Liabilities, Noncurrent 4.78B USD -13.5%
Liabilities 181B USD +1.93%
Common Stocks, Including Additional Paid in Capital 50B USD +1.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax 272M USD
Retained Earnings (Accumulated Deficit) 63.9B USD +1.81%
Stockholders' Equity Attributable to Parent 77.4B USD +3.27%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 77.6B USD +3.25%
Liabilities and Equity 258B USD +2.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.56B USD -7.08%
Net Cash Provided by (Used in) Financing Activities -2.33B USD -90.1%
Net Cash Provided by (Used in) Investing Activities -762M USD +63.6%
Common Stock, Shares Authorized 3.2B shares 0%
Common Stock, Shares, Issued 1.79B shares +0.45%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.46B USD -7.59%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12B USD -6.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.01B USD -2.97%
Deferred Tax Assets, Valuation Allowance 301M USD -21.8%
Operating Lease, Liability 16.7B USD -6.33%
Payments to Acquire Property, Plant, and Equipment 743M USD +5.39%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.12B USD -33.7%
Lessee, Operating Lease, Liability, to be Paid 21.2B USD -7.28%
Operating Lease, Liability, Current 1.91B USD -0.26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.53B USD -1.21%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.68B USD -1.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.54B USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.34B USD -1.1%
Deferred Tax Assets, Operating Loss Carryforwards 272M USD -33.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 424M USD -2.75%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.17B USD -0.64%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2B USD -1.48%
Depreciation, Depletion and Amortization 1.17B USD +1.74%
Deferred Tax Assets, Net of Valuation Allowance 7.61B USD -4.94%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%